Cargando…

Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19

BACKGROUND: Acute COVID‐19–related myocardial, pulmonary, and vascular pathology and how these relate to each other remain unclear. To our knowledge, no studies have used complementary imaging techniques, including molecular imaging, to elucidate this. We used multimodality imaging and biochemical s...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Shirjel R., Vinayak, Sudhir, Shah, Adeel, Doolub, Gemina, Kimeu, Redemptar, Horn, Kevin P., Bowen, Stephen R., Jeilan, Mohamed, Lee, Kuan Ken, Gachoka, Sylvia, Riunga, Felix, Adam, Rodney D., Vesselle, Hubert, Joshi, Nikhil, Obino, Mariah, Makhdomi, Khalid, Ombati, Kevin, Nganga, Edward, Gitau, Samuel, Chung, Michael H., Shah, Anoop S. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683664/
https://www.ncbi.nlm.nih.gov/pubmed/36102258
http://dx.doi.org/10.1161/JAHA.122.026399
_version_ 1784835101980360704
author Alam, Shirjel R.
Vinayak, Sudhir
Shah, Adeel
Doolub, Gemina
Kimeu, Redemptar
Horn, Kevin P.
Bowen, Stephen R.
Jeilan, Mohamed
Lee, Kuan Ken
Gachoka, Sylvia
Riunga, Felix
Adam, Rodney D.
Vesselle, Hubert
Joshi, Nikhil
Obino, Mariah
Makhdomi, Khalid
Ombati, Kevin
Nganga, Edward
Gitau, Samuel
Chung, Michael H.
Shah, Anoop S. V.
author_facet Alam, Shirjel R.
Vinayak, Sudhir
Shah, Adeel
Doolub, Gemina
Kimeu, Redemptar
Horn, Kevin P.
Bowen, Stephen R.
Jeilan, Mohamed
Lee, Kuan Ken
Gachoka, Sylvia
Riunga, Felix
Adam, Rodney D.
Vesselle, Hubert
Joshi, Nikhil
Obino, Mariah
Makhdomi, Khalid
Ombati, Kevin
Nganga, Edward
Gitau, Samuel
Chung, Michael H.
Shah, Anoop S. V.
author_sort Alam, Shirjel R.
collection PubMed
description BACKGROUND: Acute COVID‐19–related myocardial, pulmonary, and vascular pathology and how these relate to each other remain unclear. To our knowledge, no studies have used complementary imaging techniques, including molecular imaging, to elucidate this. We used multimodality imaging and biochemical sampling in vivo to identify the pathobiology of acute COVID‐19. Specifically, we investigated the presence of myocardial inflammation and its association with coronary artery disease, systemic vasculitis, and pneumonitis. METHODS AND RESULTS: Consecutive patients presenting with acute COVID‐19 were prospectively recruited during hospital admission in this cross‐sectional study. Imaging involved computed tomography coronary angiography (identified coronary disease), cardiac 2‐deoxy‐2‐[fluorine‐18]fluoro‐D‐glucose positron emission tomography/computed tomography (identified vascular, cardiac, and pulmonary inflammatory cell infiltration), and cardiac magnetic resonance (identified myocardial disease) alongside biomarker sampling. Of 33 patients (median age 51 years, 94% men), 24 (73%) had respiratory symptoms, with the remainder having nonspecific viral symptoms. A total of 9 patients (35%, n=9/25) had cardiac magnetic resonance–defined myocarditis. Of these patients, 53% (n=5/8) had myocardial inflammatory cell infiltration. A total of 2 patients (5%) had elevated troponin levels. Cardiac troponin concentrations were not significantly higher in patients with and without myocarditis (8.4 ng/L [interquartile range, IQR: 4.0–55.3] versus 3.5 ng/L [IQR: 2.5–5.5]; P=0.07) or myocardial cell infiltration (4.4 ng/L [IQR: 3.4–8.3] versus 3.5 ng/L [IQR: 2.8–7.2]; P=0.89). No patients had obstructive coronary artery disease or vasculitis. Pulmonary inflammation and consolidation (percentage of total lung volume) was 17% (IQR: 5%–31%) and 11% (IQR: 7%–18%), respectively. Neither were associated with the presence of myocarditis. CONCLUSIONS: Myocarditis was present in a third patients with acute COVID‐19, and the majority had inflammatory cell infiltration. Pneumonitis was ubiquitous, but this inflammation was not associated with myocarditis. The mechanism of cardiac pathology is nonischemic and not attributable to a vasculitic process. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN12154994.
format Online
Article
Text
id pubmed-9683664
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96836642022-11-25 Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19 Alam, Shirjel R. Vinayak, Sudhir Shah, Adeel Doolub, Gemina Kimeu, Redemptar Horn, Kevin P. Bowen, Stephen R. Jeilan, Mohamed Lee, Kuan Ken Gachoka, Sylvia Riunga, Felix Adam, Rodney D. Vesselle, Hubert Joshi, Nikhil Obino, Mariah Makhdomi, Khalid Ombati, Kevin Nganga, Edward Gitau, Samuel Chung, Michael H. Shah, Anoop S. V. J Am Heart Assoc Original Research BACKGROUND: Acute COVID‐19–related myocardial, pulmonary, and vascular pathology and how these relate to each other remain unclear. To our knowledge, no studies have used complementary imaging techniques, including molecular imaging, to elucidate this. We used multimodality imaging and biochemical sampling in vivo to identify the pathobiology of acute COVID‐19. Specifically, we investigated the presence of myocardial inflammation and its association with coronary artery disease, systemic vasculitis, and pneumonitis. METHODS AND RESULTS: Consecutive patients presenting with acute COVID‐19 were prospectively recruited during hospital admission in this cross‐sectional study. Imaging involved computed tomography coronary angiography (identified coronary disease), cardiac 2‐deoxy‐2‐[fluorine‐18]fluoro‐D‐glucose positron emission tomography/computed tomography (identified vascular, cardiac, and pulmonary inflammatory cell infiltration), and cardiac magnetic resonance (identified myocardial disease) alongside biomarker sampling. Of 33 patients (median age 51 years, 94% men), 24 (73%) had respiratory symptoms, with the remainder having nonspecific viral symptoms. A total of 9 patients (35%, n=9/25) had cardiac magnetic resonance–defined myocarditis. Of these patients, 53% (n=5/8) had myocardial inflammatory cell infiltration. A total of 2 patients (5%) had elevated troponin levels. Cardiac troponin concentrations were not significantly higher in patients with and without myocarditis (8.4 ng/L [interquartile range, IQR: 4.0–55.3] versus 3.5 ng/L [IQR: 2.5–5.5]; P=0.07) or myocardial cell infiltration (4.4 ng/L [IQR: 3.4–8.3] versus 3.5 ng/L [IQR: 2.8–7.2]; P=0.89). No patients had obstructive coronary artery disease or vasculitis. Pulmonary inflammation and consolidation (percentage of total lung volume) was 17% (IQR: 5%–31%) and 11% (IQR: 7%–18%), respectively. Neither were associated with the presence of myocarditis. CONCLUSIONS: Myocarditis was present in a third patients with acute COVID‐19, and the majority had inflammatory cell infiltration. Pneumonitis was ubiquitous, but this inflammation was not associated with myocarditis. The mechanism of cardiac pathology is nonischemic and not attributable to a vasculitic process. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN12154994. John Wiley and Sons Inc. 2022-09-14 /pmc/articles/PMC9683664/ /pubmed/36102258 http://dx.doi.org/10.1161/JAHA.122.026399 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Alam, Shirjel R.
Vinayak, Sudhir
Shah, Adeel
Doolub, Gemina
Kimeu, Redemptar
Horn, Kevin P.
Bowen, Stephen R.
Jeilan, Mohamed
Lee, Kuan Ken
Gachoka, Sylvia
Riunga, Felix
Adam, Rodney D.
Vesselle, Hubert
Joshi, Nikhil
Obino, Mariah
Makhdomi, Khalid
Ombati, Kevin
Nganga, Edward
Gitau, Samuel
Chung, Michael H.
Shah, Anoop S. V.
Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19
title Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19
title_full Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19
title_fullStr Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19
title_full_unstemmed Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19
title_short Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19
title_sort assessment of cardiac, vascular, and pulmonary pathobiology in vivo during acute covid‐19
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683664/
https://www.ncbi.nlm.nih.gov/pubmed/36102258
http://dx.doi.org/10.1161/JAHA.122.026399
work_keys_str_mv AT alamshirjelr assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT vinayaksudhir assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT shahadeel assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT doolubgemina assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT kimeuredemptar assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT hornkevinp assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT bowenstephenr assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT jeilanmohamed assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT leekuanken assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT gachokasylvia assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT riungafelix assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT adamrodneyd assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT vessellehubert assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT joshinikhil assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT obinomariah assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT makhdomikhalid assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT ombatikevin assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT ngangaedward assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT gitausamuel assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT chungmichaelh assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19
AT shahanoopsv assessmentofcardiacvascularandpulmonarypathobiologyinvivoduringacutecovid19